CLINICAL_TRIALS
trial_result
· 2026-04-13
Clinical Trial Update: A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluating BAY3283142 for chronic kidney disease has completed, with the update noting evaluation of its efficacy and safety in partici…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED